Home › Cardiomyopathy › Connecticut
Cardiomyopathy clinical trials in Connecticut
4 studies for Cardiomyopathy are looking for participants at sites in Connecticut.
Cities in Connecticut
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Norwich
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Yale University School of Medicine - Section of Cardiology, New Haven
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
- Yale University, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06209359MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Yale University School of Medicine, New Haven
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.